Why Smart-ABI?

PROBLEM:

Symptoms don't manifest until 60% of the artery is occluded

75% of the United States population goes undiagnosed until the majority of the vessel is occluded

Manual ABI is subject to human error, cumbersome,

and is not reimbursable

 

 

 

TEST BOTH ARMS, BOTH LEGS, BOTH POSTERIOR TIBIAL AND DORSALIS PEDIS ARTERIES

AUTOMATICALLY CALCULATES ABI AND SIX ADDITIONAL MEDICAL MARKERS

DISPLAYS ACTUAL BLOOD FLOW, SIX DIFFERENT PRESSURES AND TREND RESULTS OVER TIME

Smart-ABI

Performs Quantitative Analysis Enabling Early Detection of Peripheral Artery Disease (PAD)
and Peripheral Neuropathy (PN)

PAD is a major cost burden on

the U.S. Healthcare System

 The Smart-ABI series

 INSTANTLY

provides quantitative data physicians

can use to identify risk, provide

early detection, and initiate intervention

Smart-ABI is:

  • EASY

  • IMMEDIATE

  • REIMBURSABLE

  • PATIENT/PHYSICIAN FRIENDLY REPORT 

  • TRENDING ANALYSIS

  • COST EFFECTIVE 

  • CONVENIENT 

  • ACCURATE & REPRODUCIBLE

Smart-ABI eliminates:

  • RESCHEDULING

  • 30-MINUTE TEST

  • CERTIFIED TECHNICIAN

  • HARD-TO-READ WAVEFORMS

  • WAITING FOR RESULTS

  • SPLIT FEES FOR REPORT READING

TEST.  EDUCATE.  PREVENT.

doctor with patient.jpg
dr and patient.jpg
doc-and-patient-4-PS-web.jpg

Smart-LEDA

(Lower Extremity Disease Assessment)

patient with doc.jpg

PAD Population Profile

age 50+ with history of diabetes

age 70+

age 50+ with history of smoking

It’s not about the number of patients, it’s about the type of patients.  Left untreated, the 5 year mortality rate for these patients is over 30%. It is critical this patient population is tested.

CALL US TODAY FOR AN

ON-SITE OR VIRTUAL

PRODUCT DEMO

888-802-6888

© 2020 by Hyperion Medical